Bera; Kaustav

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bera; Kaustav.The latest application filed is for "combination of radiomic and pathomic features in the prediction of prognoses for tumors".

Company Profile

9.2.8

Bera; Kaustav - Cleveland OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recurrence prognosis and prediction of added benefit of adjuvant chemotherapy in early stage non-small cell lung cancer with radiomic features on baseline computed tomography Grant 11,350,901 - Madabhushi , et al. June 7, 2	2022-06-07
Association Of Prognostic Radiomics Phenotype Of Tumor Habitat With Interaction Of Tumor Infiltrating Lymphocytes (tils) And Cancer Nuclei App 20210110928 - Vaidya; Pranjal ; et al.	2021-04-15
Predicting Tumor Prognoses Based On A Combination Of Radiomic And Clinico-pathological Features App 20210110540 - Vaidya; Pranjal ; et al.	2021-04-15
Combination Of Radiomic And Pathomic Features In The Prediction Of Prognoses For Tumors App 20210110541 - Vaidya; Pranjal ; et al.	2021-04-15
Prognosis Of Prostate Cancer With Computerized Histomorphometric Features Of Tumor Morphology From Routine Hematoxylin And Eosin Slides App 20210027459 - Madabhushi; Anant ; et al.	2021-01-28
Distinguishing hyperprogression from other response patterns to PD1/PD-L1 inhibitors in non-small cell lung cancer with pre-therapy radiomic features Grant 10,839,513 - Vaidya , et al. November 17, 2	2020-11-17
Distinguishing Minimally Invasive Carcinoma And Adenocarcinoma In Situ From Invasive Adenocarcinoma With Intratumoral And Peri-t App 20190357870 - Madabhushi; Anant ; et al.	2019-11-28
Distinguishing Hyperprogression From Other Response Patterns To Pd1/pd-l1 Inhibitors In Non-small Cell Lung Cancer With Pre-ther App 20190347789 - Vaidya; Pranjal ; et al.	2019-11-14
Predicting Recurrence And Overall Survival Using Radiomic Features Correlated With Pd-l1 Expression In Early Stage Non-small Cel App 20190259156 - Madabhushi; Anant ; et al.	2019-08-22
Recurrence Prognosis And Prediction Of Added Benefit Of Adjuvant Chemotherapy In Early Stage Non-small Cell Lung Cancer With Rad App 20190159745 - Madabhushi; Anant ; et al.	2019-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.